Published in Br Heart J on August 01, 1977
Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev (2001) 4.92
Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol (1997) 2.08
Psittacosis. West J Med (1987) 0.83
Unusual cause of atrial fibrillation. Br Med J (Clin Res Ed) (1982) 0.81
Brain stem encephalitis in ornithosis. J Neurol Neurosurg Psychiatry (1986) 0.75
INFECTIONS BY ORGANISMS OF PSITTACOSIS/LYMPHOGRANULOMA VENEREUM GROUP IN THE WEST OF SCOTLAND. Br Med J (1964) 2.83
Infective endocarditis as part of psittacosis. Lancet (1971) 2.72
Endocarditis caused by a psittacosis agent. Br Heart J (1974) 1.88
Insidious endocarditis caused by Chlamydia psittaci. Br Med J (1975) 1.45
Pet birds and acquired chronic valvar disease. Lancet (1971) 1.22
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
The present role of coronary artery surgery. Practitioner (1982) 3.08
Dermatologists should not be concerned in routine treatment of warts. Br Med J (Clin Res Ed) (1988) 2.33
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg (1990) 2.07
Direct immunofluorescent identification of respiratory syncytial virus in throat swabs from children with respiratory illness. Lancet (1968) 2.05
Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc (1992) 1.94
Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart (2001) 1.93
Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation (1998) 1.86
A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin Exp Dermatol (1990) 1.84
Natriuretic peptide system in human heart failure. Circulation (1993) 1.79
Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg (2000) 1.75
Chlamydial infection in homosexual men. Frequency of isolation of Chlamydia trachomatis from the urethra, ano-rectum, and pharynx. Br J Vener Dis (1981) 1.67
Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg (1993) 1.66
Erythromycin stearate in treating chlamydial infection of the cervix. Br J Vener Dis (1984) 1.66
Fatal granulomatous disease of childhood and benign lymphocytic infiltration of the skin (congenital dysphagocytosis). Lancet (1967) 1.62
Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant (2008) 1.56
Endothelin in human congestive heart failure. Circulation (1994) 1.56
A new porcine bioprosthesis: in vitro and in vivo evaluation. Life Support Syst (1985) 1.55
Cardiac transplantation for end-stage congenital heart defects: the Mayo Clinic experience. Mayo Cardiothoracic Transplant Team. Mayo Clin Proc (1998) 1.53
VERO cells (Cercopithecus aethiops kidney)--growth characteristics and viral susceptibility for use in diagnostic virology. (Brief report). Arch Gesamte Virusforsch (1969) 1.50
The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist. Curr Med Res Opin (1981) 1.46
Cryotherapy of hand warts--a questionnaire survey of 'consumers'. Clin Exp Dermatol (1990) 1.46
Arrhythmias after coronary bypass surgery. Br Heart J (1984) 1.46
In vitro calcification of bioprosthetic heart valves: report of a novel method and review of the biochemical factors involved. J Heart Valve Dis (1992) 1.45
Plasma albumin and haemodilution: the problem of interpretation in sequential studies. Ann Clin Biochem (1989) 1.42
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis (1995) 1.39
Disseminated toxoplasmosis in cardiac transplantation. J Clin Pathol (1984) 1.38
Respiratory dysfunction following cardiopulmonary bypass: verification of a non-invasive technique to measure shunt fraction. Respir Med (1993) 1.38
The production of fluorescent antibody reagents for virus diagnosis in the albino mouse. I. Hyperimmune anti-species serum. Arch Gesamte Virusforsch (1967) 1.37
Studies on an epidemic of respiratory disease caused by Mycoplasma pneumoniae. Br Med J (1967) 1.35
Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation (1999) 1.22
Laparoscopically assisted colectomy and wound recurrence. Lancet (1993) 1.21
Isolated pulmonary rejection after combined heart-lung transplantation. J Thorac Cardiovasc Surg (1985) 1.19
Mycoplasmas and erythema multiforme. Lancet (1967) 1.17
An improved method for the direct immunofluorescent identification of Neisseria gonorrhoeae. Bull World Health Organ (1968) 1.06
A real time 2-dimensional ultrasonic scanner for clinical use. Ultrasonics (1976) 1.04
Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. Gut (1977) 1.03
The preparation of an antiserum to adenovirus group (hexon) antigen, to be used for immunofluorescent detection of infection with different adenoviruses. Arch Gesamte Virusforsch (1971) 1.03
Two-dimensional echocardiography with a wide angle (60 degrees) sector scanner. Br Heart J (1977) 1.01
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant (1995) 1.01
Analgesia by wound infiltration after surgical excision of benign breast lumps. Ann R Coll Surg Engl (1985) 1.00
The inhibition of neuraminidase and antiviral action. Br J Pharmacol Chemother (1966) 1.00
The management of ventricular septal rupture following myocardial infarction. Q J Med (1980) 0.99
Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation. Am J Cardiol (2001) 0.98
Routine treatment of cutaneous warts: a questionnaire survey of general practitioners. J R Coll Gen Pract (1989) 0.97
Differentiation between gaseous and formed embolic materials in vivo. Application in prosthetic heart valve patients. Stroke (1994) 0.97
Synthetic retinoids for acne. Lancet (1980) 0.96
Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant (2001) 0.96
An epidemic of respiratory disease caused by Mycoplasma pneumoniae. Proc R Soc Med (1966) 0.96
Rapid method for the preparation of replicate microslide tissue culture to facilitate immunofluorescent identification of unknown virus isolates. J Clin Pathol (1967) 0.93
Treatment of extensive virus warts with etretinate (Tigason) in a patient with sarcoidosis. Clin Exp Dermatol (1983) 0.92
HIV testing in Glasgow Genito-Urinary Medicine Clinics 1985-1987. Scott Med J (1988) 0.92
A prospective evaluation of the Björk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses. Circulation (1986) 0.92
Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. Am J Physiol (1997) 0.92
Coronary artery disease patients' perception of their health and expectations of benefit following coronary artery bypass grafting. J Adv Nurs (2000) 0.92
Assessment of changes in general health status using the short-form 36 questionnaire 1 year following coronary artery bypass grafting. Eur J Cardiothorac Surg (2000) 0.92
Determinants of survival and recovery of left ventricular function after aortic valve replacement. Ann Thorac Surg (1993) 0.91
The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting. Heart (2001) 0.91
Removal of contaminating protein from high titre virus suspensions to be used in the production of antisera for immunofluorescence. Arch Gesamte Virusforsch (1971) 0.91
In vitro blood compatibility of surface-modified polyurethanes. Biomaterials (1998) 0.91
Sudden coronary death in Glasgow: nature and frequency of acute coronary lesions. Br Heart J (1987) 0.91
Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. Biochem Biophys Res Commun (1992) 0.89
Variable intrathoracic airways obstruction masquerading as asthma. Br Med J (Clin Res Ed) (1983) 0.89
Outbreak of non-specific urethritis associated with the presence of complement-fixing antibodies to the LB4 strain of TRIC agent. Br J Vener Dis (1966) 0.89
Platelet aggregatory responses to low-dose collagen are maintained in hirudin-anticoagulated whole blood for 24 h when stored at room temperature. Platelets (2001) 0.89
Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation. Transplantation (1999) 0.88
Arrhythmia prophylaxis after coronary artery surgery. A randomised controlled trial of intravenous magnesium chloride. Eur J Cardiothorac Surg (1993) 0.88
An outbreak of Mycoplasma pneumoniae infection in a nuclear submarine. JAMA (1966) 0.88
Transvascular and intracardiac two-dimensional echocardiography. Echocardiography (1990) 0.87
Dynamic modelling of prosthetic chorded mitral valves using the immersed boundary method. J Biomech (2006) 0.87
Reimplantation injury after lung transplantation in a rat model. J Heart Transplant (1987) 0.87
Acute vascular rejection. Xenotransplantation (1998) 0.87
Transcranial Doppler detection of microemboli in prosthetic heart valve patients: dependency upon valve type. Eur J Cardiothorac Surg (1996) 0.87
A new design for polyurethane heart valves. J Heart Valve Dis (2001) 0.87
New polyurethane heart valve prosthesis: design, manufacture and evaluation. Biomaterials (1996) 0.87
Confocal laser scanning microscopy of calcified bioprosthetic heart valves. J Heart Valve Dis (1994) 0.86
Calcification and stress distribution in bovine pericardial heart valves. J Biomed Mater Res (1992) 0.86
Prostacyclin in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg (1982) 0.86
Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. J Clin Pathol (1988) 0.86
Steroid-responsive bronchiolitis after human heart-lung transplantation. J Thorac Cardiovasc Surg (1986) 0.85
Non-invasive assessment by Doppler ultrasound of 155 patients with bioprosthetic valves: a comparison of the Wessex porcine, low profile Ionescu-Shiley, and Hancock pericardial bioprostheses. Br Heart J (1986) 0.85
Systematic evaluation of distribution of transgene expression after adenovirus-mediated gene transfer to the transplanted heart. Transpl Int (1998) 0.85
Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin Proc (1996) 0.85
Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol (2002) 0.85
Management of biliary tract disease in heart and lung transplant patients. Surgery (2000) 0.85
Primary tissue failure in pericardial heart valves. J Thorac Cardiovasc Surg (1987) 0.85
Highly efficient ex vivo gene transfer to the transplanted heart by means of hypothermic perfusion with a low dose of adenoviral vector. J Thorac Cardiovasc Surg (2000) 0.85
On the origin of cerebrovascular microemboli associated with prosthetic heart valves. Neurol Res (1995) 0.84
The production of fluorescent antibody reagents for virus diagnosis in the albino mouse. II. Coupling of mouse immune globulin with fluorescein isothiocyanate (FITC). Arch Gesamte Virusforsch (1967) 0.84
A double blind study of prostacyclin in cardiopulmonary bypass surgery. Br J Haematol (1981) 0.84
Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass. Thromb Res (2000) 0.84
Detection of microemboli by transcranial Doppler ultrasound. Tex Heart Inst J (1996) 0.83
Myocardial infarction related to coronary artery bypass graft surgery. Br Heart J (1984) 0.83
Growth potential of the immature transplanted lung. An experimental study. J Thorac Cardiovasc Surg (1990) 0.83
Immediate effects of pericardiectomy. J Thorac Cardiovasc Surg (1973) 0.83
Transesophageal echocardiography in critically ill patients. Am J Cardiol (1990) 0.83